Page last updated: 2024-11-02

oxybutynin and Prostatic Diseases

oxybutynin has been researched along with Prostatic Diseases in 1 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Prostatic Diseases: Pathological processes involving the PROSTATE or its component tissues.

Research Excerpts

ExcerptRelevanceReference
"Oxybutynin chloride (Ditropan) and placebo were randomized in a double-blind trial to determine the effectiveness of the test agent in controlling post-transurethral pain and spasm."9.04Oxybutynin chloride in control of post-trasurethral vesical pain and spasm. ( Paulson, DF, 1978)
"Oxybutynin chloride (Ditropan) and placebo were randomized in a double-blind trial to determine the effectiveness of the test agent in controlling post-transurethral pain and spasm."5.04Oxybutynin chloride in control of post-trasurethral vesical pain and spasm. ( Paulson, DF, 1978)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paulson, DF1

Trials

1 trial available for oxybutynin and Prostatic Diseases

ArticleYear
Oxybutynin chloride in control of post-trasurethral vesical pain and spasm.
    Urology, 1978, Volume: 11, Issue:3

    Topics: Clinical Trials as Topic; Cyclohexanes; Double-Blind Method; Female; Humans; Male; Mandelic Acids; P

1978